Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
9 pending office actions • 5 clients • 8 examiners • 8 art units • 0 of 9 (0%) have an AI response strategy ready
Forge IP, PLLC has 9 pending office actions in Biotechnology & Pharmaceuticals and 431 career applications. Its resolved allowance rate is 91.18%, while allowed matters average 3.17 office actions. The record combines a focused current docket with a recorded prosecution history in a specialized field.
The allowance rate supplies a measure of resolved outcomes, and the action average indicates the examination activity associated with allowed matters. Together, they give practitioners separate information about results and response demands. The pending docket is useful for understanding current workload, but it should not be used alone to predict the outcome of a particular biotechnology or pharmaceutical application.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (22%) |
| Double-patenting + other | 3 (33%) |
| Multi-statute (no §101) | 4 (44%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PETRITSCH, AMANDA MICHELLE | 2 | 56.6% | +25.7% |
| PAK, JOHN D | 1 | 52.3% | +37.8% |
| ARMSTRONG, SUSANNAH SIPPLE | 1 | 30.0% | +53.1% |
| YU, HONG | 1 | 31.1% | +5.7% |
| YOUNG, MICAH PAUL | 1 | 55.2% | +30.0% |
| AHMED ALI, MOHAMED K | 1 | 70.9% | +26.6% |
| HENKEL, DANIELLE B | 1 | 56.4% | +23.4% |
| LEE, BYUNG RO | 1 | 74.2% | +13.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18267008 | Apparatus For Controlling Water Consumption In Bathrooms | LEE, BYUNG RO | 34d |
| 18686557 | Multi-Layered Dextrose Tablets | ARMSTRONG, SUSANNAH SIPPLE | — |
| 18270377 | Additive Manufacturing Method And Additive Manufacturing Machine Implementing The Method | AHMED ALI, MOHAMED K | — |
| 18272643 | Super Nozzle Injection Fermentor | HENKEL, DANIELLE B | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18612007 | Carrier Systems For Cannabinoids | YOUNG, MICAH PAUL | 12d |
| 18267008 | Apparatus For Controlling Water Consumption In Bathrooms | LEE, BYUNG RO | 34d |
| 19046728 | Oral Powder Mixture With Small Sized Particles | PETRITSCH, AMANDA MICHELLE | — |
| 18958419 | Soft Chew Tablets Suitable For Antacids | PAK, JOHN D | — |
| 18894764 | Mouthwash For Oral Care Benefits | PETRITSCH, AMANDA MICHELLE | — |
| 18686557 | Multi-Layered Dextrose Tablets | ARMSTRONG, SUSANNAH SIPPLE | — |
| 18270377 | Additive Manufacturing Method And Additive Manufacturing Machine Implementing The Method | AHMED ALI, MOHAMED K | — |
| 18272643 | Super Nozzle Injection Fermentor | HENKEL, DANIELLE B | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Fertin Pharma A/S | 5 |
| Fertin Pharma Avs | 1 |
| Lines Manufacturing S.A.S | 1 |
| Unibio Tech Science A/S | 1 |
| Aguardio Aps | 1 |
| Art Unit | Apps |
|---|---|
| 1612 | 2 |
| 1699 | 1 |
| 1616 | 1 |
| 1614 | 1 |
| 1618 | 1 |
| 1743 | 1 |
| 1799 | 1 |
| 2858 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19046728 | Oral Powder Mixture With Small Sized Particles | Fertin Pharma A/S | PETRITSCH, AMANDA MICHELLE | 1612 | §103§112DP | Non-Final OA | — | Pending | Feb 06, 2025 |
| 18958419 | Soft Chew Tablets Suitable For Antacids | Fertin Pharma A/S | PAK, JOHN D | 1699 | §103Other | Non-Final OA | — | Pending | Nov 25, 2024 |
| 18894764 | Mouthwash For Oral Care Benefits | Fertin Pharma Avs | PETRITSCH, AMANDA MICHELLE | 1612 | §103§112DP | Non-Final OA | — | Pending | Sep 24, 2024 |
| 18686557 | Multi-Layered Dextrose Tablets | Fertin Pharma A/S | ARMSTRONG, SUSANNAH SIPPLE | 1616 | §102§103§112 | Non-Final OA | — | Pending | Aug 20, 2024 |
| 18612256 | Cannabinoid Self-Emulsifying Systems | Fertin Pharma A/S | YU, HONG | 1614 | §103DP | Final Rejection | — | Pending | Mar 21, 2024 |
| 18612007 | Carrier Systems For Cannabinoids | Fertin Pharma A/S | YOUNG, MICAH PAUL | 1618 | §103 | Final Rejection | 12d | Pending | Mar 21, 2024 |
| 18270377 | Additive Manufacturing Method And Additive Manufacturing Machine Implementing The Method | Lines Manufacturing S.A.S | AHMED ALI, MOHAMED K | 1743 | §102§103 | Non-Final OA | — | Pending | Jan 17, 2024 |
| 18272643 | Super Nozzle Injection Fermentor | Unibio Tech Science A/S | HENKEL, DANIELLE B | 1799 | §102§103§112 | Non-Final OA | — | Pending | Jul 17, 2023 |
| 18267008 | Apparatus For Controlling Water Consumption In Bathrooms | Aguardio Aps | LEE, BYUNG RO | 2858 | §102§103§112 | Final Rejection | 34d | Pending | Jun 13, 2023 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial91.2% of resolved applications prosecuted by Forge Ip, Pllc were allowed, across 431 applications in USPTO records.
3.17 office actions per allowed application on average.
9 pending office actions as of October 2026, for 5 clients, before 8 examiners in 8 art units.
